Seeking Alpha

Galena Biopharma (GALE) forms a partnership with Germany's Leica Biosystems to use the latter's...

Galena Biopharma (GALE) forms a partnership with Germany's Leica Biosystems to use the latter's Bond Oracle HER2 IHC System to help select patients for the Phase III trials of Galena's NeuVax breast cancer treatment. On Tuesday, Galena signed a deal with Teva for the commercialization of NeuVax in Israel. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|